- Home
- SGMO vs PVBC Comparison
SGMO vs PVBC Comparison
Compare SGMO & PVBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGMO
- PVBC
- Stock Information
- Founded
- SGMO 1995
- PVBC 1913
- Country
- SGMO United States
- PVBC United States
- Employees
- SGMO N/A
- PVBC N/A
- Industry
- SGMO Biotechnology: Biological Products (No Diagnostic Substances)
- PVBC Major Banks
- Sector
- SGMO Health Care
- PVBC Finance
- Exchange
- SGMO Nasdaq
- PVBC Nasdaq
- Market Cap
- SGMO 180.5M
- PVBC 184.9M
- IPO Year
- SGMO 2000
- PVBC 2015
- Fundamental
- Price
- SGMO $1.96
- PVBC $11.16
- Analyst Decision
- SGMO Buy
- PVBC Hold
- Analyst Count
- SGMO 3
- PVBC 1
- Target Price
- SGMO $7.00
- PVBC $12.00
- AVG Volume (30 Days)
- SGMO 11.1M
- PVBC 39.3K
- Earning Date
- SGMO 11-12-2024
- PVBC 10-24-2024
- Dividend Yield
- SGMO N/A
- PVBC N/A
- EPS Growth
- SGMO N/A
- PVBC N/A
- EPS
- SGMO N/A
- PVBC 0.32
- Revenue
- SGMO $52,291,000.00
- PVBC $55,219,000.00
- Revenue This Year
- SGMO N/A
- PVBC N/A
- Revenue Next Year
- SGMO $71.79
- PVBC $4.77
- P/E Ratio
- SGMO N/A
- PVBC $34.71
- Revenue Growth
- SGMO N/A
- PVBC N/A
- 52 Week Low
- SGMO $0.30
- PVBC $7.36
- 52 Week High
- SGMO $3.18
- PVBC $12.32
- Technical
- Relative Strength Index (RSI)
- SGMO 51.89
- PVBC 58.36
- Support Level
- SGMO $1.82
- PVBC $10.86
- Resistance Level
- SGMO $2.11
- PVBC $11.08
- Average True Range (ATR)
- SGMO 0.38
- PVBC 0.28
- MACD
- SGMO -0.10
- PVBC 0.01
- Stochastic Oscillator
- SGMO 16.44
- PVBC 62.37
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.
About PVBC Provident Bancorp Inc. (MD)
Provident Bancorp Inc provides a range of banking products and services to small and medium-sized commercial customers. It attracts deposits from the general public and uses those funds to originate loans, commercial real estate, construction and land, and commercial business loans, and to invest in securities. The company lending activities include providing commercial real estate loans, multi-family residential real estate loans, commercial business loans, construction and land development loans, one-to four-family residential loans, home equity loans & lines of credit, and consumer loans.